Clinical Trial Update: Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

View source ↗

Summary

A clinical trial in Italy is evaluating clinical characteristics and outcomes in patients with Marginal Zone Lymphoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Zone Lymphoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Marginal Zone B Cell Lymphoma | Status: RECRUITING